Bristol Myers Squibb coming up on important support.Technically Speaking
As you can see from the chart, the 47.50ish level seems to be a good source of demand, at least in the past and looks like a good entry level for a long, stopping out somewhere below. Leave some wiggle room to account for volatility.
Fundamentals
Be aware, they announce earnings before the bell on 10/27 CST.
Looks like the big slide in the stock was sparked by a failed drug trial: www.nasdaq.com
Bristol Myers sports a div yield of 3.04%: www.google.com
Div history: www.nasdaq.com
As always, know why you are buying something.
Think for yourself.
